Skip to main content
. 2017 Jun 28;2017(6):CD003351. doi: 10.1002/14651858.CD003351.pub3

NCT01326325.

Trial name or title Efficacy of low analgesic doses of ketamine associated with opioids in refractory cancer pain treatment
Methods Randomised, placebo‐controlled, double‐blind parallel group study
Participants Adult hospitalised cancer patients with refractory pain undergoing opioid treatment
Interventions IV ketamine versus placebo
Outcomes Per cent reduction average daily pain intensity score; daily average pain intensity score; patient global impression of change; daily sleep interference; opioid consumption; patient satisfaction; adverse effects
Starting date July 2011. Completed February 2013
Contact information Sylvie Rostaing‐Rigattieri, Center of Evaluation and Treatment of Pain, Saint‐Antoine Hospital, Paris, France
Notes "Completed" study, unpublished. Possibly the same study registered as NCT00484484?